drug · small molecule
sitravatinib malate
Phase 3updated 3mo agoby Bristol-Myers Squibb Co🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Unknown, with 1 investigational indication.
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying sitravatinib malate
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2m ago
Found something off?
comments(0)
5-min edit window · permanent after that